Exact Sciences Corp (NAS:EXAS)
$ 50.38 -1.57 (-3.02%) Market Cap: 9.30 Bil Enterprise Value: 11.20 Bil PE Ratio: 0 PB Ratio: 2.96 GF Score: 78/100

Exact Sciences Corp at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 10:00PM GMT
Release Date Price: $78.73 (+10.89%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Good afternoon, everyone. I'm Derik De Bruin, the senior life sciences and diagnostics tools analyst here at Bank of America, and welcome to our 2023 health care conference coming to you live from the Encore here in beautiful Las Vegas. Our next discussion group is Exact Sciences. And with us here from Exact Sciences is Kevin Conroy, Chairman and CEO; Brian Baranick, General Manager of Precision Oncology; and Megan Jones from IR. Everybody, thank you so much for making the trip, particularly since I know you just had your earnings call last night and you had a schlep in from Madison to get here. So thank you for making it in such short notice.

Questions & Answers

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

So shall we start with that. You just reported a blowout quarter. Stocks are reacting nicely. And I also then want to follow that up with a question of, it's been a long time. So I think the [good ones] were waiting for that to sort of see that.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot